These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 16878474)

  • 21. Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.
    Evans JS; Selden D; Wu G; Wright E; Horton DL; Fooks AR; Banyard AC
    J Gen Virol; 2018 Feb; 99(2):169-180. PubMed ID: 29300155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. First encounter of European bat lyssavirus type 2 (EBLV-2) in a bat in Finland.
    Jakava-Viljanen M; Lilley T; Kyheröinen EM; Huovilainen A
    Epidemiol Infect; 2010 Nov; 138(11):1581-5. PubMed ID: 20196902
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Australian lyssavirus infection.
    Uma A; Thirumalaikolundusubramanian P
    J Indian Med Assoc; 1998 Jun; 96(6):195. PubMed ID: 9834577
    [No Abstract]   [Full Text] [Related]  

  • 24. Isolation, antigenicity and immunogenicity of Lleida bat lyssavirus.
    Banyard AC; Selden D; Wu G; Thorne L; Jennings D; Marston D; Finke S; Freuling CM; Müller T; Echevarría JE; Fooks AR
    J Gen Virol; 2018 Dec; 99(12):1590-1599. PubMed ID: 29745870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Taiwan Bat Lyssavirus: In Vitro and In Vivo Assessment of the Ability of Rabies Vaccine-Derived Antibodies to Neutralise a Novel Lyssavirus.
    Shipley R; Wright E; Smith SP; Selden D; Fooks AR; Banyard AC
    Viruses; 2022 Dec; 14(12):. PubMed ID: 36560754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potential exposure to Australian bat lyssavirus, Queensland, 1996-1999.
    McCall BJ; Epstein JH; Neill AS; Heel K; Field H; Barrett J; Smith GA; Selvey LA; Rodwell B; Lunt R
    Emerg Infect Dis; 2000; 6(3):259-64. PubMed ID: 10827115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Bat lyssavirus in Thailand].
    Lumlertdacha B; Wacharapluesadee S; Chanhome L; Hemachudha T
    J Med Assoc Thai; 2005 Jul; 88(7):1011-4. PubMed ID: 16241035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EBLV-2 prevalence in the United Kingdom as determined by surveillance testing.
    Smith GC; Brookes SM; Harris SL; Aegerter JN; Jones G; Fooks AR
    Dev Biol (Basel); 2006; 125():265-71. PubMed ID: 16878484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Discussion on the article Ondrejková A et al.: Transmission of lyssavirus infections from bats to man. Klin mikrobiol inf lek 2003;9:280-3].
    Benes J; Korínková M
    Klin Mikrobiol Infekc Lek; 2004 Feb; 10(1):34. PubMed ID: 15100983
    [No Abstract]   [Full Text] [Related]  

  • 30. Genetic and Antigenetic Characterization of the Novel Kotalahti Bat Lyssavirus (KBLV).
    Calvelage S; Tammiranta N; Nokireki T; Gadd T; Eggerbauer E; Zaeck LM; Potratz M; Wylezich C; Höper D; Müller T; Finke S; Freuling CM
    Viruses; 2021 Jan; 13(1):. PubMed ID: 33419096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Active monitoring of EBLV infection in natural colonies of the mouse-eared Bat (Myotis myotis).
    Amengual B; Bourhy H; López-Roig M; Serra-Cobo J
    Dev Biol (Basel); 2008; 131():547-53. PubMed ID: 18634518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bat rabies surveillance in the former Soviet Union.
    Kuzmin IV; Botvinkin AD; Poleschuk EM; Orciari LA; Rupprecht CE
    Dev Biol (Basel); 2006; 125():273-82. PubMed ID: 16878485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaccines for lyssaviruses other than rabies.
    Nel LH
    Expert Rev Vaccines; 2005 Aug; 4(4):533-40. PubMed ID: 16117710
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rabies prophylaxis in Western Australia: the impact of Australian bat lyssavirus.
    Torvaldsen S; Watson T
    Commun Dis Intell; 1998 Aug; 22(8):149-52. PubMed ID: 9735544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of European bat lyssavirus 2 (EBLV-2) in a Daubenton's bat (Myotis daubentonii) from Magdeburg, Germany.
    Freuling CM; Kliemt J; Schares S; Heidecke D; Driechciarz R; Schatz J; Müller T
    Berl Munch Tierarztl Wochenschr; 2012; 125(5-6):255-8. PubMed ID: 22712424
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Postexposure prophylaxis after bite of a broad-winged bat with evidence of European bat lyssavirus 1 (EBLV-1)].
    Fasse J; Trawinski H; Hardt M; Lübbert C
    Inn Med (Heidelb); 2024 Jun; 65(6):608-611. PubMed ID: 38100072
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatal human rabies caused by European bat Lyssavirus type 2a infection in Scotland.
    Nathwani D; McIntyre PG; White K; Shearer AJ; Reynolds N; Walker D; Orange GV; Fooks AR
    Clin Infect Dis; 2003 Aug; 37(4):598-601. PubMed ID: 12905146
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-neutralization of antibodies induced by vaccination with Purified Chick Embryo Cell Vaccine (PCECV) against different Lyssavirus species.
    Malerczyk C; Freuling C; Gniel D; Giesen A; Selhorst T; Müller T
    Hum Vaccin Immunother; 2014; 10(10):2799-804. PubMed ID: 25483634
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabies pre-exposure prophylaxis elicits long-lasting immunity in humans.
    Mansfield KL; Andrews N; Goharriz H; Goddard T; McElhinney LM; Brown KE; Fooks AR
    Vaccine; 2016 Nov; 34(48):5959-5967. PubMed ID: 27997343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccinating the vampire bat Desmodus rotundus against rabies.
    Almeida MF; Martorelli LF; Aires CC; Barros RF; Massad E
    Virus Res; 2008 Nov; 137(2):275-7. PubMed ID: 18761044
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.